Áàêó/16.02.22/  Àçåðáàéäæàíå çà ïîñëåäíèå ñóòêè çàðåãèñòðèðîâàíî 7 148 íîâûõ ñëó÷àåâ çàðàæåíèÿ êîðîíàâèðóñíîé èíôåêöèåé (COVID-19), 7 387 ïàöèåíòîâ âûëå÷èëèñü, 22 – ñêîí÷àëèñü, ñîîáùèë 16 ôåâðàëÿ Îïåðàòèâíûé øòàá ïðè Êàáèíåòå ìèíèñòðîâ.
Âñåãî ñ íà÷àëà ïàíäåìèè â ñòðàíå áûëî âûÿâëåíî 759 753 ôàêòà çàðàæåíèÿ COVID-19, â òîì ÷èñëå 703 952 ÷åëîâåê èçëå÷èëèñü, 9 127 – ñêîí÷àëèñü, àêòèâíî áîëüíûõ – 46 674.
Çà ïîñëåäíèå ñóòêè â ñòðàíå ïðîâåäåíî 18 346 òåñòîâ íà âûÿâëåíèå COVID-19.—06Â-
